|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Credibility of rules and economic growth: Evidence from a worldwide survey of the private sector显示文摘 | Brunetti A Kisunko G Weder B | 1998 | World Bank Economic Review1998，12，3： | 1 |
| 2 | The prognostic value of soluble inter|eukin-6 receptor in patients with multiple myeloma 显示文摘 | Stasi R Brunetti M Parma A | 1998 | Cancer1998，82，10： | 1 |
| 3 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) compared with infusional fluorouracil,leucovorin,and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | | 0，，13： | 1 |
| 4 | CT appearance of the normal appendix in adults显示文摘 | Tamburrini S Brunetti A Brown M | 2005 | Eur Radiol2005，15，20： | 1 |
| 5 | Glucocorticoid-Induced osteo- porosis in children with 21-hydroxylase deficiency 显示文摘 | Ventura A Brunetti G Colucci S | 2013 | Biomed Res Int2013，5，25： | 1 |
| 6 | WGS reaction in a membrane reactor using a porous stainless steel supported silica membrane显示文摘 | Brunetti A | 2007 | Chem Eng Process2007，46，： | 1 |
| 7 | Coronary atherosclerosis and a rare combinination of congenital coronary anomalies in STelevation acute myocardial infarction显示文摘 | Brunetti N D Cuculo A Ruggiero A | 2012 | J Cardiowasc Med(Hagerstown)2012，14，4： | 1 |
| 8 | Lower cardiovascular mortality with atorvastatin and rosuvastatin vs simvastatin: Data from 'moderate- intensity'statin users in an observational reg- istry on chronic heart failure (Daunia Heart Failure Registry) 显示文摘 | Brunetti ND Correale M Totaro A | 2015 | Int J Cardiol2015，7，2： | 1 |
| 9 | Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest 显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 10 | Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage显示文摘 | FRID M G BRUNETTI J A BURKE D L | 2006 | Am J Pathol2006，168，2： | 1 |
| 11 | Coronary artery eclasia is related to coronary slow flow and inflammatory activation 显示文摘 | Brunetti ND Salvemini G Cueulo A | 2014 | Ather-osclerosis2014，233，2： | 1 |
| 12 | Plasticizer for poly(vinylchloride) from cardanol as a renewable resource material显示文摘 | Greco A Brunetti D Renna G | 2010 | Polymer Degradation and Stability2010，95，21： | 1 |
| 13 | Spontaneous and glucocor-ticoid-induced apoptosis in human mature T lymphocytes显示文摘 | Brunetti M Martelli N Colasante A | 1995 | Blood1995，86，11： | 1 |
| 14 | Perspectives on the contribution of genetics to the pathogenesis of type 2 diabetes mellitus 显示文摘 | Brunetti A Chiefari E Foti D | 2011 | Recenti Prog Med2011，102，12： | 1 |
| 15 | Phase Ⅲ trial of infusional fluorouraeil, leucovorin, oxaliplatin, and irinoteean ( FOLFOXI- RI) compared with infusional fluorouraeil, leueovorin, and irino- tecan(FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oneologieo Nord Ovest显示文摘 | Faleone A Rieci S Brunetti I | 2007 | J Clin Oncol2007，25，13： | 1 |
| 16 | 1H MR spectroscopy in patients with metastatic brain tumors:a multicenter study显示文摘 | Sijens PE Knopp MV Brunetti A | 1995 | Magn Reson Med1995，33，6： | 1 |
| 17 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) compared with infusional fluorouracil,leucovorin,and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | 2007 | J Clin Oncol2007，25，： | 1 |
| 18 | Sclerostin is over expressed by plasma cells from multiple myeloma patients显示文摘 | Brunetti G Oranger A Mori G | 2011 | Ann N Y Acad Sci2011，12，37： | 1 |
| 19 | Insulin resistance and cancer risk:an over- view of the pathogenetic mechanisms显示文摘 | Brunetti A | 2012 | J Diabetes Res2012，2012，： | 1 |
| 20 | Phase Ⅲ trial of infusional fluorouracil,leucovorin,oxaliplatin,and irinotecan (FOLFOXIRI) compared with infusional fluorouracil,leucovorin,and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:the Gruppo Oncologico Nord Ovest显示文摘 | Falcone A Ricci S Brunetti I | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员